U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C49H54N8O8
Molecular Weight 883.0019
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VELPATASVIR

SMILES

COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C2=CC=CC=C2)C3=NC=C(N3)C4=CC=C5C(COC6=CC7=C(C=CC8=C7NC(=N8)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C=C56)=C4

InChI

InChIKey=FHCUMDQMBHQXKK-CDIODLITSA-N
InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
VELPATASVIR
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
VELPATASVIR [MI]
Common Name English
VELPATASVIR [JAN]
Common Name English
velpatasvir [INN]
Common Name English
Velpatasvir [WHO-DD]
Common Name English
EPCLUSA COMPONENT VELPATASVIR
Brand Name English
VELPATASVIR COMPONENT OF EPCLUSA
Brand Name English
VELPATASVIR [USAN]
Common Name English
VOSEVI COMPONENT VELPATASVIR
Common Name English
VELPATASVIR COMPONENT OF VOSEVI
Common Name English
VELPATASVIR [ORANGE BOOK]
Common Name English
GS-5816
Code English
Classification Tree Code System Code
NCI_THESAURUS C281
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
WHO-ATC J05AP56
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
NDF-RT N0000191256
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
FDA ORPHAN DRUG 554816
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
NCI_THESAURUS C783
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
WHO-ATC J05AP55
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
Code System Code Type Description
LACTMED
Velpatasvir
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
SMS_ID
100000166177
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
NDF-RT
N0000190107
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
DRUG CENTRAL
5154
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
FDA UNII
KCU0C7RS7Z
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
NDF-RT
N0000190108
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
CAS
1377049-84-7
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
ChEMBL
CHEMBL3545062
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
NDF-RT
N0000190113
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY Breast Cancer Resistance Protein Inhibitors [MoA]
RXCUI
1799206
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
NDF-RT
N0000190109
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]
WIKIPEDIA
Velpatasvir
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
CHEBI
133009
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
NDF-RT
N0000185503
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY P-Glycoprotein Inhibitors [MoA]
USAN
CD-110
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
MERCK INDEX
m11941
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
PUBCHEM
67683363
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
DAILYMED
KCU0C7RS7Z
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
NCI_THESAURUS
C152851
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
INN
9960
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
DRUG BANK
DB11613
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
EVMPD
SUB180213
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
EPA CompTox
DTXSID70722565
Created by admin on Sat Dec 16 09:45:19 UTC 2023 , Edited by admin on Sat Dec 16 09:45:19 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of VELPATASVIR
METABOLITE (PARENT)
Structure of DESMETHYL-VELPATASVIR
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966